Key Takeaways Charles River Laboratories International, Inc. (CRL) reported second-quarter 2025 adjusted earnings per share (EPS) of $3.12, which rose 11.4% year over year. The figure surpassed the Zacks Consensus Estimate by 24.8%. On a GAAP basis, the company reported earnings of $1.06 per share compared with the year-ago quarter's level of $1.74. CRL's Q2 Revenues Revenues totaled $1.03 billion, which beat the Zacks Consensus Estimate by 5%. The top line rose 0.6% from the year-ago quarter's level (down ...